Navigation Links
First-ever therapeutic offers hope for improving blood transfusions
Date:6/25/2013

Case Medical Center, and director, Harrington Discovery Institute, UH Case Medical Center.

"One important aspect of our study is the insight that knowledge of banked blood's SNO-Hb status may be used to judge the efficacy of a transfusion," Stamler said.

This information would allow physicians to discriminate between blood donations that may cause harm versus those that will have restorative effects following transfusion.

The research team hypothesized that the loss of NO compromises the ability to dilate blood vessels and thereby deliver oxygen to tissues, which is critical for survival. Red blood cells lacking NO instead would plug small blood vessels and cause heart attacks and kidney failure. In contrast, restoration of NO would ensure oxygen delivery.

The study, funded by the National Heart Lung and Blood Institute (NHLBI), found that mice, rats and sheep transfused with untreated banked blood had decreased oxygen levels in skeletal muscle and other tissuesexactly the opposite of what would have been predicted. By contrast, in animals transfused with renitrosylated (NO repleted) red blood cells, tissue oxygenation improved. In addition, researchers applied the same treatment to anemic animals and found improved blood flow, tissue oxygenation, and kidney function.

Stamler explained that these results demonstrate that restoration of blood NO levels may be useful in treating and preventing a wide variety of conditions, including heart attacks and strokes, and kidney damage following surgery. The findings also may offer new promise for patients with sickle disease, malaria and other blood disorders. In addition, the data suggest that Stamler's therapeutic is a simple way to reverse the potential toxicity of regular blood transfusions.

The Food and Drug Administration considers a transfusion successful if 75 percent of the banked red blood cells are circulating in the body of the recipient 24 hours after admi
'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. First-ever 3-D stress map of developing embryonic heart sheds light on why defects form
2. Professor publishes on first-ever imaging of cells growing on spherical surfaces
3. China poised to accept first-ever non-animal test method for cosmetics
4. First-ever release of endangered burying beetles in Missouri
5. Scientists complete first-ever emperor penguin count from space
6. Drug development venture links translational research, business to launch new therapeutics
7. Autism discovery paves way for early blood test and therapeutic options
8. Salk scientists find potential therapeutic target for Cushings disease
9. Novel therapeutic approaches to cure chronic HBV infection
10. Intranasal neuropeptide Y may offer therapeutic potential for post-traumatic stress disorder
11. BUSM study reveals therapeutic targets to alter inflammation, type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... June 30, 2014  Aware, Inc. (NASDAQ: ... services, previously announced on June 26, 2014 that its ... of $1.75 per share, or approximately $40 million in ... 10, 2014 and a payment date of July 24, ... it had set an ex-dividend date for this special ...
(Date:7/10/2014)... COMMACK, N.Y. , July 2, 2014 ... Inc. (ABD) to announce the appointment of the world-renowned ... its Board of Directors. Dr. Ginsburg, with ... two facilities: NY Presbyterian Hospital and Good Samaritan Regional ... Breathing Pacemaker since the late 1980,s and is considered ...
(Date:7/10/2014)... , July 3, 2014 Research ... addition of the "Global Gesture Recognition & ... - Forecasts to 2020" report to their ... Global Gesture Recognition & Touch-Less Sensing Market ... around for a while, but the companies were ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... mammoths and ancient American horses may have been grazing ... than previously thought. After plucking ancient DNA from frozen ... cutting-edge techniques to uncover "genetic fossils" of both species ... 10,500 calendar years. This new evidence suggests that at ...
... look forward to ultra-low powered or self powered electronic ... is made possible with power management and cutting-edge energy ... and higher energy efficiency in electronic devices and systems. ... for power management and energy harvesting. To pre-position the ...
... part of an international team that has used DNA samples ... of North America,s woolly mammoths and ancient horses. The ... Duane Froese and his colleagues counters an important extinction theory, ... concluded that more than half of the large mammals in ...
Cached Biology News:Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been upgraded for ... a second treatment cup to help prevent and smooth skin ... thinner on the edges for a softer contact with the ... surfaces on the face, neck and décolleté. Choose to use ... such as the cheeks and neck, or opt for the ...
(Date:7/10/2014)... 10, 2014  Kainos Capital, a firm specializing in ... that it has acquired the Slim-Fast brand from Unilever. ... Terms of the transaction were not disclosed. ... business that markets ready-to-drink shakes, powders, bars and snacks ... and in the United Kingdom ...
(Date:7/10/2014)... 2014 -- According to the International Atomic Energy ... comes from terrorists acquiring sufficient quantities of plutonium ... crude nuclear explosive device. The IAEA also notes ... involved gram-level quantities, which can be challenging to ... a new study appearing this week in the ...
(Date:7/10/2014)... extremely challenging because there are many genetic variants that ... Now investigators reporting in the July 3rd issue of ... describe a strategy that may help reveal how such ... environmental exposures to affect the development of the nervous ... predispose individuals to schizophrenia. , The work takes ...
Breaking Biology Technology:Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Kainos Capital Acquires Slim-Fast From Unilever 2Sensitive detection method may help impede illicit nuclear trafficking 2New strategy could uncover genes at the root of psychiatric illnesses 2
... HER3 Total Protein ... Assays in Collaborative Biomarker Study, SOUTH SAN FRANCISCO, ... ) today announced that scientific,collaborators have presented additional clinical ... means to measure HER2 total,protein and homodimer levels and ...
... Medline Industries, Inc., the,nation,s largest privately held manufacturer ... has signed a three-year agreement to,purchase mouth rinse ... personal care, infection control and diagnostic use in ... in the healthcare market, we are,happy to extend ...
... The 21st Century Health Care Forum discusses the future of Continuing ... ... FRANCISCO, June 2 Accredited online nursing courses,are replacing traditional classroom-based ... flexibility in,their credentialing options., Ann Johnson, CEO of Wild Iris ...
Cached Biology Technology:Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 2Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 3Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 4Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 5Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting 6Medline Signs 3-Year Purchasing Agreement for Mouth Rinse From Chester Labs 2Modernizing Continuing Education With Online Courses 2
Amyloid stain....
...
Human sIL-2R/CD25 ELI-PAIR Kit...
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: